
CAS 1638744-06-5
:Formel:C25H29BrN8O2
InChl:InChI=1S/C25H29BrN8O2/c1-15(26)10-12-33-21-22(30-24(33)32-11-6-7-17(27)13-32)31(3)25(36)34(23(21)35)14-20-28-16(2)18-8-4-5-9-19(18)29-20/h4-5,8-10,17H,6-7,11-14,27H2,1-3H3/b15-10-/t17-/m1/s1
InChI Key:KOVUTSTYXMWMHQ-XBNGYDHASA-N
SMILES:CC1=NC(=NC2=CC=CC=C12)CN3C(=O)C4=C(N=C(N4C/C=C(/C)\Br)N5CCC[C@H](C5)N)N(C3=O)C
Filtern nach
Reinheitsanteil
0
100
|
0
|
50
|
90
|
95
|
100
6 Produkte gefunden.
- Niedrigster Preis
- Höchster Preis
- Niedrigste Reinheit
- Höchste Reinheit
- Schnellste Lieferung
Linagliptin Related Compound D
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormel:C25H29BrN8O2Farbe und Form:Light Yellow PowderMolekulargewicht:552.15968(R,Z)-8-(3-Aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione
CAS:(R,Z)-8-(3-Aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dioneFormel:C25H29BrN8O2Reinheit:96%Molekulargewicht:553.45(R,Z)-8-(3-Aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione
CAS:Formel:C25H29BrN8O2Reinheit:96%Farbe und Form:SolidMolekulargewicht:553.4542Linagliptin EP Impurity D (Linagliptin USP Related Compound D)
CAS:Formel:C25H29BrN8O2Farbe und Form:Pale Yellow SolidMolekulargewicht:553.47N-Des-(2-butyn-1-yl)-N-(3-bromo-2-buten-1-yl) Linagliptin (E/Z Mixture)
CAS:Applications N-Des-(2-butyn-1-yl)-N-(3-bromo-2-buten-1-yl) Linagliptin is an impurity of Linagliptin (L465900); a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.
References Prabavathy, N. et al.: Int. J. Pharm. Bio. Sci., 2, 438 (2011); Deacon, C.F.: Diab. Obes. Metab., 13, 7 (2011)Formel:C25H29BrN8O2Farbe und Form:NeatMolekulargewicht:553.45






